Cure, a top-ranked Terran with strong recent results in GSL and other events, faced veteran Protoss sOs in this best-of-3 group stage opener. Cure entered with superior overall form and a favorable head-to-head record against sOs, who has shown inconsistency after earlier 2026 results including losses in international events. The matchup highlighted classic Terran versus Protoss dynamics on maps like Ruby Rock LE, where execution in mid-game transitions and army compositions often decide series. No major roster or patch changes affected preparation, though broader meta shifts from prior balance updates favored aggressive playstyles. Group implications added pressure, with Cure positioned as the clear frontrunner based on current standings momentum and consistent high-level performances.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日Cure vs sOs
Moneyline
$110 Vol.
Map 1 Winner
$816 Vol.
Map Handicap
$100 Vol.
Total Games
$100 Vol.
This market will resolve to "Cure" if Cure win the match against sOs.
This market will resolve to "sOs" if sOs win the match against Cure.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
マーケット開始日: May 19, 2026, 6:00 PM ET
Cure vs sOs
Moneyline
$110 Vol.
Map 1 Winner
$816 Vol.
Map Handicap
$100 Vol.
Total Games
$100 Vol.
This market will resolve to "Cure" if Cure win the match against sOs.
This market will resolve to "sOs" if sOs win the match against Cure.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
マーケット開始日: May 19, 2026, 6:00 PM ET
Cure, a top-ranked Terran with strong recent results in GSL and other events, faced veteran Protoss sOs in this best-of-3 group stage opener. Cure entered with superior overall form and a favorable head-to-head record against sOs, who has shown inconsistency after earlier 2026 results including losses in international events. The matchup highlighted classic Terran versus Protoss dynamics on maps like Ruby Rock LE, where execution in mid-game transitions and army compositions often decide series. No major roster or patch changes affected preparation, though broader meta shifts from prior balance updates favored aggressive playstyles. Group implications added pressure, with Cure positioned as the clear frontrunner based on current standings momentum and consistent high-level performances.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日外部リンクに注意してください。
外部リンクに注意してください。


外部リンクに注意してください。
外部リンクに注意してください。
よくある質問